Inactive
Notice ID:SPE2D219R0051
Pramipexole di-HCl Modification SPE2D220D0091 P00006 to incorporate Drug Supply Chain Security Act language into solicitation for subject contract. Modification SPE2D220D0091 P00005 to incorporate cla...
Pramipexole di-HCl Modification SPE2D220D0091 P00006 to incorporate Drug Supply Chain Security Act language into solicitation for subject contract. Modification SPE2D220D0091 P00005 to incorporate clause FAR 52.204-27 Prohibition on a ByteDance Covered Application (JUN 2023) into subject contract. Modification P00004 SPE2D220D0091 issued to Invoke Option 3 effective April 29, 2023 through April 28, 2024. Modification P00003 SPE2D220D0091 issued to Invoke Option 2 effective April 29, 2022 through April 28, 2023. Modification P00002 SPE2D220D0091 issued to Invoke Option 1 effective April 29, 2021 through April 28, 2022. Modification P00001 SPE2D220D0091 to incorporate FAR 52.204-24 and FAR 52.205-25 into contract. Amendment 0006 SPE2D2-19-R-0051 Pramipexole di-HCl to extend the closing date to December 31, 2019 at 3:00 PM EST. To correct page 4 of solicaiiton block 9; titled, Submisssion Instructions for "hand carried" offers building number. To corect pages 29-30 for the "Statement of Work" of solicitation. To incorporate FAR Clause 52.204-24 Representation Regarding Certain Telecommunications and Video Surveillance Services or Equipment into the solicitation.